Biomerica, Inc.
BMRA
$3.88
$0.123.19%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.42% | 27.81% | 7.39% | 25.91% | -27.27% |
| Total Depreciation and Amortization | -1.00% | 3.09% | 0.00% | 3.19% | 3.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.35% | 57.45% | -46.59% | -47.46% | 313.58% |
| Change in Net Operating Assets | 40.45% | 59.36% | -310.58% | 133.33% | -163.29% |
| Cash from Operations | -32.11% | 41.15% | -28.74% | 42.03% | -113.90% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.88% | -- | -- | 100.00% | -166.67% |
| Cash from Investing | 87.88% | -- | -- | -50.00% | -33.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 350.77% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -158.33% | -- | -- | -- | -- |
| Cash from Financing | 356.84% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 75.00% | 33.33% | -- | -100.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 253.13% | 66.81% | -17.49% | 36.69% | -112.53% |